Actuate Therapeutics (ACTU) Interest Expenses (2023 - 2025)
Actuate Therapeutics (ACTU) posted quarterly Interest Expenses of $55769.0 for Q4 2025, up 206.6% year-over-year from $18189.5 in Q4 2024, and up 1001.5% quarter-over-quarter from $5063.0 in Q3 2025.
Actuate Therapeutics (ACTU) Interest Expenses (2023 - 2025) Analysis & Trends
Actuate Therapeutics (ACTU) has reported Interest Expenses for 3 consecutive years, with $55769.0 the latest figure, recorded in Q4 2025.
- In Q4 2025, Interest Expenses rose 206.6% year-over-year to $55769.0; the TTM figure through Dec 2025 stood at $70957.0 (up 283.47% YoY), while the FY2025 annual figure was $1.7 million, down 95.58% from the prior year.
- Interest Expenses improved to $55769.0 in Q4 2025 per ACTU's latest filing, from $5063.0 in the prior quarter.
- Across five years, Interest Expenses topped out at $55769.0 in Q4 2025 and bottomed at -$52316.0 in Q4 2024.
- Historically, Interest Expenses has averaged $4315.4 across 3 years, with a median of $5063.0 in 2023.
- Annual changes were most pronounced in 2024 — Interest Expenses plunged 1133.3% — and 2025, when it soared 206.6%.
- Actuate Therapeutics' Interest Expenses stood at $5063.0 in 2023, then slumped by 1133.3% to -$52316.0 in 2024, then jumped by 206.6% to $55769.0 in 2025.
- Business Quant data shows ACTU's Interest Expenses at $55769.0 in Q4 2025, $5063.0 in Q3 2025, and $5062.0 in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Expense (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | 11.00 Mn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | - |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 39.74 Mn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | 82.05 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | -4.89 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | 20.27 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | 93.62 Mn |
| 10 | Actuate Therapeutics | 30.08 Mn | 30.08 Mn | - | 5,063.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 55,769.00 |
| Dec 31, 2025 | 55,769.00 |
| Sep 30, 2025 | 5,063.00 |
| Sep 30, 2025 | 5,063.00 |
| Jun 30, 2025 | 5,062.00 |
| Jun 30, 2025 | 5,062.00 |
| Mar 31, 2025 | 5,063.00 |
| Mar 31, 2025 | 5,063.00 |
| Dec 31, 2024 | -52,316.00 |
| Dec 31, 2024 | -52,316.00 |
| Sep 30, 2024 | 3,489.00 |
| Sep 30, 2024 | 3,489.00 |
| Jun 30, 2024 | 5,076.00 |
| Jun 30, 2024 | 5,076.00 |
| Mar 31, 2024 | 5,076.00 |
| Mar 31, 2024 | 5,076.00 |
| Dec 31, 2023 | 5,063.00 |
| Dec 31, 2023 | 5,063.00 |
| Sep 30, 2023 | 5,062.00 |
| Sep 30, 2023 | 5,062.00 |